376592-93-7Relevant articles and documents
An improved process for the preparation of Eltrombopag Olamine and its intermediates
-
, (2021/07/30)
The present invention relates to an improved process for the purification of Eltrombopag olamine of compound of formula (2). The present invention also relates to an improved process for the preparation of Eltrombopag olamine intermediates and further conversion to Eltrombopag olamine of a compound of formula (2).
Preparation method of drug intermediate for treating idiopathic blood diseases
-
Paragraph 0039-0072, (2021/03/30)
The invention provides a preparation method of a drug intermediate for treating idiopathic blood diseases, which comprises the following steps: by using 2'-hydroxy-3'-nitrobiphenyl-3-carboxylic acid as a starting material and adopting a hydrazine hydrate-iron-carrier reduction method, avoiding the conventional Pd/C hydrogenation reduction reaction conditions, and carrying out aftertreatment by regulating the pH value and filtering, and the operability of amplify production is strong. Compared with Pd/C, the price advantage of hydrazine hydrate is obvious, the material cost can be greatly reduced, and the method is very suitable for industrial production.
Synthetic method of eltrombopag intermediate and synthetic method of eltrombopag
-
Paragraph 0043-0057, (2020/05/29)
The invention relates to the field of medicine synthesis, in particular to a synthesis method of an eltrombopag intermediate and a synthesis method of eltrombopag. The synthesis method of the eltrombopag intermediate comprises the following steps: mixing 2'-hydroxyl-3'-nitrobiphenyl-3-carboxylic acid or 5'-chloro-2'-hydroxyl-3'-nitrobiphenyl-3-carboxylic acid with an alkali, a catalyst and water,introducing hydrogen, and carrying out a hydrogenation reaction to form the eltrombopag intermediate. The synthesis steps are simplified, the generation of impurities is reduced, and the yield and purity are improved.